Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials

By afschroeder • June 25, 2026

Møller Jensen C, Zargari Marandi R, Moestrup KS, Mourad A, Mena Lora AJ, Sherman BT, Vock DM, Nordwall JA, Carson JM, Peiffer-Smadja N, Aggarwal NR, Naiman NE, Brown SM, Barrett TW, Hatlen T, Kjærgaard VS, Chang W, Sydes MR, Lundgren J, Jensen TO; STRIVE Network and ITAC and TICO Study Groups. Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials. JAMIA Open. 2026 Jun 23;9(3):ooag079. doi: 10.1093/jamiaopen/ooag079. PMID: 42344108; PMCID: PMC13289610.

Tags: biostatistics, Harbor UCLA, Infectious Diseases, machine learning, Medical Informatics, Publications, Randomized Controlled Trial, SARS-CoV-2

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

Tai D, Kim KI, Shah P, Park D, Kim L, Li J, Jung C, Guzman S, Brar G, Wu S, Castillo D. Impact of metastatic[...]

Investigating the Kidney-Gut-Brain Axis in CKD: Uremic Toxins and Brain Microhemorrhages

Zhao Y, Lee SM, Li W, Floriolli D, Chang P, Narasaki Y, You AS, Kalantar-Zadeh K, Rhee CM, Liu H, Tran T, Paganini-Hill A, Fisher[...]

Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels in Patients with Chronic Kidney Disease

Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels[...]